Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: consensus of the scientific societies SED, SEEN and SEEP

Anales de Pediatría·Nov 19

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

There is a consensus among scientific societies SED, SEEN, and SEEP on screening, staging, and follow-up of type 1 diabetes in preclinical stages. However, reports from various outlets seem to be unrelated to this consensus, instead covering topics such as cancer screening, Parkinson's disease, and HIV. The only relevant information appears to be related to type 1 diabetes screening and treatment, including the approval of a treatment to delay its onset in young children.

Full coverage

From Uncertainty to Empowerment: How To Prepare for Type 1 Screening

Making Sense of Diabetes·Oct 24

Redefining type 1 diabetes: Early identification, staging, and clinical implications for pediatric care

Contemporary Pediatrics·Nov 20

FDA Approves Tzield to Delay Onset of Stage 3 Type 1 Diabetes in Young Children

Pharmaceutical Executive·Apr 23

Data-driven clinical decision support tool for diagnosing mild cognitive impairment in Parkinson’s disease

Nature·Jan 12

ISOSS HIV report (for pregnancies between 1 April 2022- 31 March 2023)

GOV.UK·Dec 11

Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium

Wiley & Sons·Mar 30

Lung Cancer: Diagnosis, Treatment Principles, and Screening

American Academy Of Family Physicians | AAFP·May 16

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

New England Journal of Medicine·Jun 29

View original report at Anales de Pediatría ↗

Fetching the latest headlines…